American Association of Individual Investors3d
Why Theratechnologies Inc.’s (THTX) Stock Is Up 28.57%
Theratechnologies Inc.’s THTX share price has surged by 28.57%, which has investors questioning if this is right time to sell ...
Verywell Health on MSN1d
Bariatric Surgery May Improve Outcomes for Patients With MASH, Study Finds
Research shows weight loss surgery can help reduce the risk of severe liver problems for some patients with MASH.
Medscape2d
Nonalcoholic Steatohepatitis: Risk Factors and Diagnosis
† NASHTest is a combination of age, gender, height, weight serum triglycerides, cholesterol, α2-macroglobulin, apolipoprotein A1, haptoglobin, γ ...
The American Journal of Managed Care4d
New Therapies Expanding the MASH Treatment Landscape
Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...
Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD
A minimally invasive therapy, the TIF 2.0 procedure reconstructs the gastroesophageal valve and restores its function as a reflux barrier. TIF 2.0 can also be combined consecutively with a surgical ...
Medscape5d
Current Management of Patients With Nonalcoholic Fatty Liver Disease
Liver biopsy and noninvasive markers should be used to stage and grade nonalcoholic steatohepatitis (NASH) in patients. Though liver biopsy remains the 'suboptimal' gold standard for diagnosis of ...
Verywell Health on MSN3d
Gallstones May Be the First Sign of Fatty Liver Disease
Experts explain what we know about the connection between gallstones and MASLD, and what you can do to reduce the risk of ...